Dopamine D2 receptor antagonists prevent Δ9-tetrahydrocannabinol-induced antinociception in rats

European Journal of Pharmacology

Volumn 384, Issue 2-3, 1999, Pages 153-156

  Carta, Giovanna ^a   Gessa, Gian Luigi ^b   Nava, Felice ^b  

^a Neuroscience Scarl   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

9 Tetrahydrocannabinol; (+) Bromocriptine; ( ) Quinpirole; Analgesia; Dopamine; S( ) Raclopride; S( ) Sulpiride; SR 141716A

Indexed keywords

BROMOCRIPTINE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DRONABINOL; QUINPIROLE; RACLOPRIDE; RIMONABANT; SULPIRIDE;

ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HOT PLATE TEST; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

ANALGESICS, NON-NARCOTIC; ANIMALS; BROMOCRIPTINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; MALE; NOCICEPTORS; PAIN; PIPERIDINES; PYRAZOLES; QUINPIROLE; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SULPIRIDE; TETRAHYDROCANNABINOL;

EID: 0033428637     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00696-2     Document Type: Article

References (10)

1. Calignano A., La Rana G., Giuffrida A., Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature. 394:1998;277-281.
2. Chen J., Paredes W., Lowinson J.H., Gardner E.L. Delta-9 tetrahydrocannabinol enhances pre-synaptic dopamine efflux in medial prefrontal cortex. Eur. J. Pharmacol. 190:1990;259-260.
3. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 258:1941;517-523.
4. 1 receptors by cannabinoids. Eur. J. Neurosci. 10:1998;2825-2830.
5. Eddy N.B., Liembach J.H. Synthetic analgesic (II): diethylbutenyl and dithienylbutylamines. J. Pharmacol. Exp. Ther. 105:1953;385-393.
6. 1 receptors. Eur. J. Pharmacol. 341:1998;39-44.
7. Lichtman A.H., Martin B.R. Spinal and supraspinal components of cannabinoid-induced antinociception. J. Pharmacol. Exp. Ther. 258:1991;517-523.
8. 9-THC, WIN 55,212-2 and anandamide in mice. Neurosci. Lett. 263:1999;29-32.
9. Tricklebank M.D., Hutson P.H., Curzon G. Involvement of dopamine in the antinociceptive response to footshock. Psychopharmacology. 82:1984;185-188.
10. Zarrindast M.R., Nassiri-Rad S., Pazouki M. Effects of dopaminergic agents on antinociception in formalin test. Gen. Pharmacol. 32:1999;517-522.